Keytruda and Padcev generated promising topline results for those with muscle-invasive bladder cancer who are ineligible for ...

With the end of the pandemic, sales of Pfizer’s PFE COVID products, Comirnaty and Paxlovid, have declined from their peak. However, Pfizer’s non-COVID operational revenues are improving, driven by its ...